SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 31, 2002
CardioGenesis Corporation
(Exact Name of Registrant as Specified in Charter)
| | | | | |
| California | | 000-28288 | | 77-0223740 |
| |
| |
|
(State or Other Jurisdiction
of Incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
| | | | | |
26632 Towne Centre Drive, Suite 320,
Foothill Ranch, California
| | | |
92610
|
| | | |
|
| (Address of Principal Executive Offices) | | | | (Zip Code) |
Registrant’s telephone number, including area code: (714) 649-5000
(Former Name or Former Address, if Changed Since Last Report)
TABLE OF CONTENTS
Item 5. Other Events
On December 31, 2002, the Registrant issued a press release titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice,” a copy of which is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 7. Financial Information, Pro Forma Financial Information and Exhibits
(a) Not applicable.
(b) Not applicable.
(c) Exhibits:
Pursuant to General Instruction F of Form 8-K, the following documents are incorporated by reference herein and attached as exhibits hereto:
| | | |
| Exhibit | | Description |
| |
|
| 99.1 | | Press release of CardioGenesis Corporation dated December 31, 2002, titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice.” |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this current report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | CARDIOGENESIS CORPORATION |
| | | | | |
| Date: January 3, 2003 | | By: | | /s/ DARRELL F. ECKSTEIN |
| | | | |
|
| | | | | Darrell F. Eckstein
President, Chief Operating Officer
and Acting Chief Financial Officer |
EXHIBIT INDEX
| | | |
| Exhibit | | Description |
| |
|
| 99.1 | | Press release of CardioGenesis Corporation dated December 31, 2002, titled “CardioGenesis Corporation to Appeal Nasdaq Delisting Notice.” |
